Trials / Unknown
UnknownNCT02484872
Has Inflammation a Significant Implication in Lung Cancer Evolution?
L'Inflammation A-t-elle Une Implication Significative Dans l'évolution du Cancer Bronchique?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- European Lung Cancer Working Party · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Systemic inflammation is a potential prognostic factor in cancer. Inflammation scores as the Glasgow score have been tested in cancer and specifically in lung cancer patients. The aim of the study is to look at the prognostic and predictive value of inflammation during cancer evolution, on the risk of complications leading to ICU admission and the risk of death.
Detailed description
Patients with newly diagnosed lung cancer will be eligible. All patients will have a blood sampling allowing testing inflammation and cytokine analyses at diagnosis, during work-up and in case of complication.
Conditions
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2022-12-01
- Completion
- 2023-12-01
- First posted
- 2015-06-30
- Last updated
- 2021-08-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02484872. Inclusion in this directory is not an endorsement.